From
StayCurrentMD
Social Determinants of Health Influence on Survival in Wilms Tumor, Neuroblastoma, and Hepatoblastoma
hosted by Dr. Sophia Schermerhorn
Chapter 1 of 1 · Evidence & Research
Social Determinants and Pediatric Oncology Survival
Expert statements on this page
No expert statements were drawn from this page.
Host summaries · secondary, not cited in answers
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Video
Hepatoblastoma with Dr. Greg Tiao
CCHMC Pediatric Surgery · Published Mar 2022
Video
Update Course 2023 - Updates in the use of ICG
19 min · Published Aug 2023
Video
Long-Term Follow-Up of Surgical Outcomes for Patients With Wilms Tumor and Neuroblastoma
1 min · Published Feb 2026
Video
Update Course Rewind: Staging and Management of Neuroblastoma 2022
Published Jun 2023
Podcast
Journal of Pediatric Surgery Article Review: The Disruption Score
12 min · Published Aug 2021
Video
The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report
59 s · Published Mar 2026
Video
Updated Favorable histology Wilms tumor risk stratification: Rationale for future Children’s Oncology Group clinical trials
53 s · Published Apr 2026
Video
Impact of Pulmonary Tumor Burden in Favorable Histology Wilms Tumor Outcomes: A Report From the Children's Oncology Group Study AREN053
1 min · Published Mar 2026
Video
Quick Literature Updates Ep 21
4 min · Published Sep 2025
Video
Update Course Rewind: Updates in Wilms Management 2024
4 min · Published Sep 2025
Video
Eficacia y efectos renales tardíos de la cirugía conservadora de nefronas en el tratamiento del tumor de Wilms unilateral: una revisión sistemática y un metanálisis
1 min · Published Mar 2024
Video
Efficacy and late kidney effects of nephron-sparing surgery in the management of unilateral Wilms tumor
53 s · Published Mar 2024
Video
Pediatric Surgical Oncology Research Collaborative (PSORC): Studying Rare Pediatric Tumors
56 s · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Pooling Patients to Study Rare Pediatric Tumors: An Introduction to PSORC
56 s · Published May 2026
Video
The fetal frontier: A review of current and emerging fetal therapies for genetic diseases
44 s · Published May 2026
Video
Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients
1 min · Published May 2026
Video
Tricuspid valve surgery in transposition of the great arteries with a systemic right ventricle
46 s · Published May 2026
What the experts said
Study was a retrospective analysis of 12,000 patients with neuroblastoma, Wilms tumor, and hepatoblastoma from the National Cancer Database
Socioeconomic disadvantage score was created for each patient based on median household income and education level in their local communities
The most disadvantaged children were more likely to have worse survival for Wilms tumor and neuroblastoma
After adjusting for tumor size, grade, treatment, and comorbidities, socioeconomic effects on survival remained present
Hazard ratio for socioeconomic disadvantage was 2.02 for Wilms tumor
Hazard ratio for socioeconomic disadvantage was 1.29 for hepatoblastoma
Pediatric oncology outcomes depend on tumor biology, treatment received, and social determinants of health
Identifying socioeconomic risk factors is necessary to close equity gaps and improve survival for all children with solid tumors